Hypermethylation of estrogen receptor-alpha promoter is associated with BRCA1 methylation in estrogen receptor-negative breast cancers

被引：0
|
作者：
Wei, MJ [1 ]
Dignam, J [1 ]
Fackenthal, J [1 ]
Sveen, L [1 ]
Hagos, F [1 ]
Grushko, T [1 ]
Olopade, OI [1 ]
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2003年 / 82卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
279
引用
收藏
页码：S67 / S67
页数：1
相关论文
共 50 条
  • [1] Increased CpG methylation of the estrogen receptor gene in BRCA1-linked estrogen receptor-negative breast cancers
    William B Archey
    Kristen A McEachern
    Mark Robson
    Kenneth Offit
    Susan AJ Vaziri
    Graham Casey
    Åke Borg
    Bradley A Arrick
    Oncogene, 2002, 21 : 7034 - 7041
  • [2] Increased CpG methylation of the estrogen receptor gene in BRCA1-linked estrogen receptor-negative breast cancers
    Archey, WB
    McEachern, KA
    Robson, M
    Offit, K
    Vaziri, SAJ
    Casey, G
    Borg, Å
    Arrick, BA
    ONCOGENE, 2002, 21 (46) : 7034 - 7041
  • [3] Estrogen receptor α, BRCA1, and FANCF promoter methylation occur in distinct subsets of sporadic breast cancers
    Wei, Minjie
    Xu, Jinhua
    Dignam, James
    Nanda, Rita
    Sveen, Lise
    Fackenthal, James
    Grushko, Tatyana A.
    Olopade, Olufunmilayo I.
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 111 (01) : 113 - 120
  • [4] Estrogen receptor α, BRCA1, and FANCF promoter methylation occur in distinct subsets of sporadic breast cancers
    Minjie Wei
    Jinhua Xu
    James Dignam
    Rita Nanda
    Lise Sveen
    James Fackenthal
    Tatyana A. Grushko
    Olufunmilayo I. Olopade
    Breast Cancer Research and Treatment, 2008, 111 : 113 - 120
  • [5] Promoter methylation of BRCA1 is associated with estrogen, progesterone and human epidermal growth factor receptor-negative tumors and the prognosis of breast cancer: A meta-analysis
    Guo, Taiyan
    Ren, Yongyong
    Wang, Boyuan
    Huang, Yingze
    Jia, Shuting
    Tang, Wenru
    Luo, Ying
    MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (06) : 1353 - 1360
  • [6] Transactivation of the estrogen receptor promoter by BRCA1
    Archey, William B.
    Arrick, Bradley A.
    CANCER CELL INTERNATIONAL, 2017, 17
  • [7] Transactivation of the estrogen receptor promoter by BRCA1
    William B. Archey
    Bradley A. Arrick
    Cancer Cell International, 17
  • [8] NFIB is a potential target for estrogen receptor-negative breast cancers
    Moon, Hyeong-Gon
    Hwang, Ki-Tae
    Kim, Jeong-Ah
    Kim, Hee Sung
    Lee, Min-Joo
    Jung, Eun-Mi
    Ko, Eunyoung
    Han, Wonshik
    Noh, Dong-Young
    MOLECULAR ONCOLOGY, 2011, 5 (06) : 538 - 544
  • [9] GATA3 Is a Marker of Estrogen Receptor-Positive but Not Estrogen Receptor-Negative Breast Cancers
    Piscuoglio, S.
    Wen, Y. H.
    Martelotto, L. G.
    Rocco, E. Guerini
    Akram, M.
    Jungbluth, A. A.
    Brogi, E.
    Weigelt, B.
    Reis-Filho, J. S.
    MODERN PATHOLOGY, 2014, 27 : 76A - 76A
  • [10] Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancers
    Nadine Tung
    Alexander Miron
    Stuart J Schnitt
    Shiva Gautam
    Katharina Fetten
    Jennifer Kaplan
    Yosuf Yassin
    Ayodele Buraimoh
    Ji-Young Kim
    Attila M Szász
    Ruiyang Tian
    Zhigang C Wang
    Laura C Collins
    Jane Brock
    Karen Krag
    Robert D Legare
    Dennis Sgroi
    Paula D Ryan
    Daniel P Silver
    Judy E Garber
    Andrea L Richardson
    Breast Cancer Research, 12
12345